Joung-Liang Lan

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

Medicine, Immunology, Pharmacology +11

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Wen‐Hung Chung, Lieh-Bang Liou, C.C. Chu et al. · Proceedings of the National Academy of Sciences · 2005 · 1.3K citations

Life Sciences, Genetics, Immunology +12

Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case–control study

Hsin‐Hua Chen, Nicole Huang, Yi‐Ming Chen et al. · Annals of the Rheumatic Diseases · 2012 · 176 citations

Medicine, Chronic Disease Prevention, Clinical Epidemiology +10

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy

Joung-Liang Lan, Yi‐Ming Chen, Tsu‐Yi Hsieh et al. · Annals of the Rheumatic Diseases · 2011 · 173 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck

Ju-Pi Li, Chia-Yu Yang, Huai-Chia Chuang et al. · Nature Communications · 2014 · 134 citations · Full text

Life Sciences, Immunology, Molecular Biology +14